Expert Discusses Immunotherapy Advancements in a Rapidly Changing GU Field – Targeted Oncology
Targeted OncologyExpert Discusses Immunotherapy Advancements in a Rapidly Changing GU FieldTargeted OncologyPD-L1 expression is used as a marker [for immunotherapy] in lung cancer, but it is not used as a significant marker in GU malignancies. Now, we … Continue reading
